Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives

. 2020 Nov ; 24 (4) : 1025-1042. [epub] 20191111

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31713185

Grantová podpora
IGA_PrF_2019_020 Internal Grant Agency of Palacký University
CZ.02.1.01/0.0/0.0/16_019/0000868 Ministry of Education, Youth and Sports of the Czech Republic
LTC17072 Ministry of Education, Youth and Sports of the Czech Republic
P40 OD010440 ODCDC CDC HHS - United States
PP-91B/19 Research, Development and Innovation Fund of Kaunas University of Technology
P40 OD010440 ODCDC CDC HHS - United States

Odkazy

PubMed 31713185
DOI 10.1007/s11030-019-10010-3
PII: 10.1007/s11030-019-10010-3
Knihovny.cz E-zdroje

A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...